iifl-logo

Share India Securities Ltd Directors Report

Add as a Preferred Source on Google
₹179.32
(-1.30%)
Nov 20, 2026|03:55:19 PM

Share India Securities Ltd Share Price directors Report

Dear Members,

Share India Securities Limited

Unit no. 615 and 616, 6th Floor, X-Change Plaza,

Dalal Street Commercial Co-operative Society Limited,

Road 5E, Block 53, Zone 5, Gift City,

Gandhinagar,

Gujarat - 382050

Your Directors have pleasure in presenting the 32nd Boards Report of the Company for the financial year ended March 31,2026, along with the Audited Standalone and Consolidated Financial Statements of the Company and Auditors Report thereon.

1. Financial Highlights

The Companys financial performance for the year under review along with previous years figures is given hereunder:

(Amount in Lakh except EPS)
Standalone Consolidated
Particulars For the year ended March 31,2026 For the year ended March 31,2025 For the year ended March 31, 2026 For the year ended March 31,2025
Total Income 1,24,679.52 1,15,841.72 1,48,884.97 1,46,950.09
Expenses (Excluding Interest and Depreciation) 73,422.22 75,644.34 89,989.57 93,166.24
Profit before Interest, Depreciation & Taxation 51,257.30 40,197.38 58,895.40 53,783.85
Interest 10,421.40 6,793.59 13,124.84 8,945.37
Depreciation 1,365.09 1,420.52 1,723.54 1,779.85
Profit before Taxation 39,470.81 31,983.27 44,047.02 43,058.63
(Less)/Add: Tax Expenses or credit (9,701.77) (7,320.08) (11,602.86) (10,250.17)
Profit for the year 29,769.04 24,663.19 32,444.16 32,808.46
Other Comprehensive Income (163.19) (793.98) 12.75 (720.96)
Total Comprehensive Income 29,605.85 23,869.21 32,456.91 32,087.50
Basic EPS (Rs.) 13.61 11.73 14.79 15.58
Diluted EPS (Rs.) 13.58 11.22 14.76 14.90
Opening Balance of Retained Earnings 1,00,801.36 78,542.33 1,35,471.82 1,05,316.59
Closing Balance of Retained Earnings 1,28,264.99 1,00,801.36 1,65,316.19 1,35,471.82

2. State of Company?s Affairs

The financial year under review was characterized by a demanding & challenging business environment and several external factors that influenced overall market dynamics. Notwithstanding these challenges, the Company exhibited strong resilience through sound managerial practices, robust risk mitigation strategies, and a disciplined operational framework, which enabled it to effectively adapt to the changing business landscape.

During the financial year 2025-26, the Company, on a standalone basis, recorded a 7.86% growth in revenue from operations compared to the preceding financial year. The Company?s profitability also improved significantly, with Profit After Tax (PAT) increasing by 20.70%, reflecting stronger operational performance and effective cost management during the year.

A comprehensive review of the Companys performance, key business developments, opportunities, challenges, and strategic initiatives is presented in the Management Discussion and Analysis (“MDA”) Report. The MDA Report forms an integral part of this Annual Report and has been prepared in accordance with Schedule V of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”).

3. Consolidated Financial Performance Review and Analysis

The Company achieved the consolidated revenue from operations of 1,47,025.58 Lakhs for the year ended March 31, 2026 reflecting an increase of 1.50 % as compared to 1,44,856.84 Lakhs in the previous year. The Company earned consolidated net profit of 32,444.16 Lakhs in the year ended March 31, 2026 marking a decline of 1.11 % as compared to 32,808.46 Lakhs reported in the previous year.

4. Capital Structure

The Authorized Share Capital of the Company stands at 50,00,00,000/- (Rupees Fifty Crore Only) divided into 25,00,00,000 equity shares of 2.00/- (Rupees Two Only) each.

During the year under review, the Companys paid-up share capital increased pursuant to the allotment of 6,05,915 equity shares under its Employees Stock Option Schemes. Consequently, the issued and paid-up equity share capital of the Company increased from 21,82,19,615 as at the beginning of the year to 21,88,25,530 as at March 31,2026. The details of such allotments are set out below:

a. Share India Employees Stock Option Scheme - II

Pursuant to the applicable provisions of the Companies Act, 2013 (“the Act”) read with the rules framed thereunder and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the Company has also implemented Share India Employees Stock Option Scheme - II (“Share India ESOS II”) for the benefit of eligible employees.

During the year under review, the Company has allotted 1,250 fully paid-up equity shares of face value of 2/- (Rupees Two each only) upon exercise of 1250 options under Share India ESOS II.

b. Share India Employees Stock Option Scheme, 2022

Pursuant to the applicable provisions of the Act read with the rules framed thereunder and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, the Company has implemented the Share India Employees Stock Option Scheme, 2022 (“Share India ESOS 2022”) for the benefit of eligible employees, as determined by the Nomination and Remuneration Committee.

During the year under review, upon exercise of options by eligible employees, the Company has allotted an aggregate of 6,04,665 fully paid-up equity shares of face value of 2/- (Rupees Two each only) each at an exercise price of 2/- per option under the said Scheme.

The equity shares allotted under Share India ESOS-II and Share India ESOS 2022 rank pari passu with the existing equity shares of the Company in all respects and are entitled to all corporate benefits, including dividend, if any, declared by the Company after the date of allotment.

In compliance with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021, a certificate from the Secretarial Auditors confirming implementation of the above Schemes have been obtained.

The statutory disclosures as mandated under Rule 12(9) of the Companies (Share Capital and Debentures) Rules, 2014 and the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 are available on the Companys website. (Click here to view)

Your Company has not issued equity shares with differential rights as to dividend, voting or otherwise.

Further, it has also not issued any Sweat Equity Shares.

5. Non-Convertible Debentures

During the year under review, the Company issued Secured, Listed, Rated, Taxable, Transferable, Redeemable and Fully Paid-up Non-Convertible Debentures (“NCDs”) on a private placement basis. The NCDs are listed on the Wholesale Debt Market Segment of BSE Limited. The details of the issuances are as follows:

1. 5,000 NCDs of 1,00,000/- (Rupees One Lakh Only) each aggregating to 50,00,00,000/- (Rupees Fifty Crores Only) (“Series A NCDs”)

2. 4,990 NCDs of 1,00,000/- (Rupees One Lakh Only) each aggregating to 49,90,00,000/- (Rupees Forty-nine Crores Ninety Lakh Only); (“Series B NCDs”) and

3. 3,500 NCDs of 1,00,000/- (Rupees One Lakh Only) each aggregating 35,00,00,000/- (Rupees Thirty-Five Crores Only) (“Second Issue NCDs”).

The proceeds raised from the aforesaid issuances were utilised solely for the purposes stated in the respective Private Placement Offer Letters. There has been no deviation or variation in the utilisation of the proceeds from the objects stated therein.

The Company has appointed Axis Trustee Services Limited, having its corporate office at The Ruby, 2nd Floor, SW 29, Senapati Bapat Marg, Dadar (West), Mumbai - 400028, as the Debenture Trustee for the aforesaid NCD issuances.

The Board of Directors, at its meeting held on May 19, 2026, approved the proposal for early redemption of Series A NCDs and Series B NCDs, which were issued and allotted by the Company on a private placement basis on June 23, 2025, subject to receipt of the necessary approvals, on such date as may be determined by the Company in terms of the applicable SEBI Regulations.

The Company convened a meeting of the debenture holders for the said purpose. The proposal for such early redemption was duly approved by the debenture holders at their meeting held on September 01,2026.

Further, the Company has also raised funds through private placements of Secured, Listed, Rated, Taxable, Transferable, Redeemable and Fully Paid-up NCDs. On July 08, 2026, the Company issued 50,000 NCDs (“NCD Series - C”), having a face value of 10,000/- (Rupees Ten Thousand only) each, aggregating to 50,00,00,000/- (Rupees Fifty Crores only). Thereafter, on July 31, 2026, the Company issued

1.50.000 NCDs (“NCD Series - D”), having a face value of 10,000/- (Rupees Ten Thousand only) each, aggregating to 1,50,00,00,000 (Rupees One Hundred Fifty Crores only). Both NCD Series C and NCD Series D are listed on the Wholesale Debt Market Segment of BSE Limited.

Further, on August 21, 2026, the Company issued

75.000 Non-Convertible Debentures (“NCD Series - E”), each having a face value of INR 10,000/- (Indian Rupees Ten Thousand Only), aggregating to INR 75,00,00,000/- (Indian Rupees Seventy-Five Crores Only). All the series of NCDs are listed on the wholesale Debt Market Segment of BSE Limited.

6. Foreign Currency Convertible Bonds

During the year under review, the Board of Directors considered approved a proposal to raise funds through the issuance of Foreign Currency Convertible Bonds (“FCCBs”) of an aggregate value not exceeding USD 50 Million, on a private placement basis, subject to the approval of the Members and other regulatory and statutory authorities, as may be required. The said proposal was also approved by the Members of the Company, by way of a Special Resolution at their Extra-Ordinary General Meeting held on December 17, 2025.

7. Dividend

During the year under review, the Company has paid the following interim dividends:

1st interim dividend: 0.30/- (Thirty Paisa only) per equity share of face value of 2/- each;

2nd interim dividend: 0.40/- (Forty Paisa only) per equity share of face value of 2/- each; and

3rd interim dividend: 0.40/- (Forty Paisa only) per equity share of face value of 2/- each.

We are pleased to inform that the Board of Directors at its meeting held on May 19, 2026, recommended a final dividend of 0.50/- (Fifty Paisa only) per equity share of face value of 2/- each for financial year 2025-26 to Members of the Company.

Pursuant to Regulation 43A of the Listing Regulations, the Board of Directors of the Company has formulated and adopted a Dividend Distribution Policy. The said policy is available on the website of the Company. (Click here to view).

8. Transfer to Investor Education and Protection Fund

The requirement of transferring the unpaid dividend/ relevant shares, to the Investor Education and Protection Fund, has not yet become applicable to the Company.

However, the Company actively undertake proactive measures to reduce unclaimed dividends and facilitate timely receipt of dividends and other investor communications. The Company also maintains a robust investor grievance redressal mechanism to ensure prompt resolution of concerns raised by shareholders and debenture holders.

9. Public Deposits

Your Company has neither invited nor accepted any deposits from public within the meaning of Sections 73 and 76 of the Act read with Companies (Acceptance of Deposits) Rules, 2014 during the financial year ended March 31, 2026. Therefore, the details in terms of Rule 8(5)(v) and 8(5)(vi) of aforementioned rules are not required to be provided.

10. Transfer to Reserves

There is no amount proposed to be transferred to reserves for financial year 2025-26.

11. Annual Return

In accordance with Section 92(3) read with Section 134(3)(a) of the Act, the Annual Return of the Company for the financial year ended March 31,2026 is available on the Companys website. (Click here to view)

12. Subsidiaries/Joint Ventures/Associates

The Company does not have any Associate Company or Joint Venture. However, the Company has following Subsidiaries as on March 31,2026:

Sl. No. Name of the Company Status
1. Share India Capital Services Private Limited Wholly-owned Subsidiary
2. Share India Fincap Private Limited Wholly-owned Subsidiary
3. Share India Global Pte. Ltd. Wholly-owned Subsidiary
4. Share India Smile Foundation Wholly-owned Subsidiary
5. Share India Wealth Multiplier Solutions Private Limited* Wholly-owned Subsidiary
6. Share India Securities (IFSC) Private Limited Wholly-owned Subsidiary
7. Total Securities (IFSC) Private Limited Wholly-owned Subsidiary
8 Share India AlgoPlus Private Limited Wholly-owned Subsidiary
9. Algowire Trading Technologies Private Limited Subsidiary
10. uTrade Solutions Private Limited Subsidiary
11. Share India Insurance Brokers Private Limited Subsidiary
12 Silverleaf Securities Research Private Limited Subsidiary
13 Share India Cred Capital Private Limited** Subsidiary

Notes:

*Share India Wealth Multiplier Solutions Private Limited was incorporated with the Registrar of Companies, Kanpur, on November 06, 2025.

** Share India Cred Capital Private Limited was incorporated with the Registrar of Companies, Kanpur, on January 06, 2026.

***The Board of Directors, at its meeting held on July 24, 2026, approved the acquisition of 100% of the equity share capital of Enshrine Leasing and Infotech Private Limited. Upon completion of the acquisition, Enshrine Leasing and Infotech Private Limited will become a wholly owned subsidiary of the Company.

The policy for determining Material Subsidiaries as approved by the Board is uploaded on the Companys website. (Click here to view)

Pursuant to the provisions of Section 129(3) of the Act, a statement containing the salient features of the financial statements of our subsidiaries for the financial year ended March 31,2026, in the prescribed format AOC-1, is attached to the Consolidated Financial Statements of the Company (refer note no. 61 of Consolidated Financial Statements).

Highlights of the financial performance of our Subsidiaries & Wholly-owned Subsidiaries as on March 31, 2026 is annexed herewith as Annexure - 8.

13. Change in the Nature of Business

There has been no change in the nature of business of your Company during the financial year 2025-26.

14. Scheme of Amalgamation of Silverleaf Capital Services Private Limited with the Company

The Board of Directors of both Silverleaf Capital Services Private Limited (“Transferor Company”) and Share India Securities Limited (“Transferee Company”), at their respective meetings held on March 18, 2024, approved the Scheme of Amalgamation of the Transferor Company with the Transferee Company and their respective shareholders and creditors under Sections 230 to 232 and other applicable provisions of the Act. The proposed amalgamation is intended to enhance operational efficiencies, realise business synergies, streamline the management structure and facilitate optimum utilisation of resources.

Subsequently, pursuant to the sub-division of the equity shares of the Transferee Company from 10/- per equity share to 2/- per equity share, which became effective on June 27, 2024, the Scheme was suitably modified to reflect the revised capital structure and was approved by the Board of Directors on August 05, 2024. Further, on September 04, 2025, the Board approved an updated Scheme reflecting the latest share capital position and revised business activities of the Company.

During the financial year under review, the Company received No Objection / Observation Letter from BSE Limited and National Stock Exchange of India Limited dated July 09, 2025 and July 11, 2025, respectively, in relation to Scheme.

Pursuant to receipt of the above-mentioned letters, the Company filed the First Joint Motion Petition before the Honble National Company Law Tribunal, Ahmedabad Bench-I (“Tribunal”) and pursuant to the Order dated October 17, 2025 (date of pronouncement) read with Order dated November 24, 2025 (date of pronouncement), passed by the Honble Tribunal, separate meetings of the Equity Shareholders and Unsecured Creditors of the Transferor Company - Silverleaf Capital Services Private Limited, and the Equity Shareholders, Non-Convertible Debenture (“NCD”) Holders, Secured Creditors and Unsecured Creditors of the Transferee Company - Share India Securities Limited, were convened and held on March 13, 2026.

The Scheme was duly approved by the requisite majority at all the aforesaid meetings of the Transferor Company and the Transferee Company, in accordance with the provisions of Sections 230 to 232 and other applicable provisions of the Act.

Subsequently, on March 25, 2026, the Company filed the Joint Second Motion Petition before the Honble Tribunal seeking final approval of the Scheme of Amalgamation. On August 20, 2026, the Honble NCLT passed an order approving the Scheme of Amalgamation.

The Company is in the process of giving effect to the aforesaid Amalgamation and is undertaking the necessary steps to complete the same in accordance with the applicable provisions of law and regulatory requirements.

15. Details of Directors or Key Managerial Personnel appointed / resigned during the year

• During the year under review:

1. At the 31st Annual General Meeting held on September 29, 2025, the Members approved the re-appointment of Mr. Sachin Gupta (DIN: 00006070) and Mr. Vijay Girdharlal Vora (DIN: 00333495), Directors of the Company, who retired by rotation pursuant to Section 152(6) of the Act and, being eligible, offered themselves for re-appointment.

2. The Members also approved the re-appointment of Mr. Suresh Kumar Arora (DIN: 00412523) as Whole-time Director of the Company for a further term of five consecutive years, effective from June 01, 2026 to May 30, 2031, upon completion of his existing term of office.

3. The Members approved the continuation of the directorship of Dr. Gopalapillai Prasanna Kumar (DIN: 01804161) as a Non-Executive Independent Director of the Company beyond the age of 75 years, in accordance with the applicable provisions of the Act and the Listing Regulations.

4. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors, at its meeting held on January 27, 2026, approved the appointment of Mr. Arun Kumar Jain (DIN: 07563704) as an Independent Director of the Company for a term of five consecutive years. The said appointment was subsequently approved by the Members of the Company by Special Resolution passed through Postal Ballot on May 21,2026.

As the appointment was subject to the prior approval of the stock exchanges, which was received on March 05, 2026, the appointment of Mr. Jain became effective from March 05, 2026.

Pursuant to Rule 8(5)(iiia) of the Companies (Accounts) Rules, 2014, as amended, the Board is of the opinion that Mr. Arun Kumar Jain is a person of integrity and possesses the requisite expertise, experience and proficiency required for discharging the duties and responsibilities of an Independent Director.

5. Based on the recommendation of the Nomination and Remuneration Committee, taking into consideration the satisfactory outcome of the performance evaluation of the Directors conducted in March 2025, the Board of Directors, through a circular resolution passed on February 27, 2026, approved the re-appointment of Mr. Piyush Mahesh Khandelwal (DIN: 06951293) as a NonExecutive Independent Director of the Company for a second term of five consecutive years with effect from March 03, 2026. The said re-appointment was subsequently approved by the Members of the Company by Special Resolution passed through Postal Ballot on May 21,2026.

• Subsequent to the close of the financial year ended March 31,2026:

1. Mr. Subhash Chander Kalia (DIN: 00075644) resigned from the position of Non-Executive Independent Director of the Company with effect from June 02, 2026. The Board placed on record its sincere appreciation for the valuable contributions and guidance provided by him during the tenure of association with the Company.

2. In accordance with the provisions of the Act and the Articles of Association of the Company, Mr. Parveen Gupta (DIN: 00013926) and Mr. Kamlesh Vadilal Shah (DIN: 00378362), Directors of the Company, are liable to retire by rotation at the forthcoming Annual General Meeting and, being eligible, have offered themselves for re-appointment. Based on the recommendations of the Nomination and Remuneration Committee, the Board has recommended their re-appointment for the approval of the Members.

3. Mr. Shanti Kumar Jain (DIN: 07720091) ceased to be a Non-Executive Independent Director of the Company with effect from August 27, 2026, upon attaining the age of 75 years. In view of the requirements of Regulation 17(1 A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in the absence of the requisite shareholders approval for continuation beyond the age of 75 years, he ceased to hold office as an Independent Director of the Company. The Board places on record its sincere appreciation for the valuable guidance, insights and contributions made by Mr. Jain during his tenure and wishes him the very best in his future endeavours.

4. Based on the recommendation of the Nomination and Remuneration Committee, taking into consideration the satisfactory outcome of the performance evaluation of the Directors conducted in March 2025, the Board of Directors, at its meeting held on September 04, 2025, approved, subject to the approval of the Members, the re-appointment of Mr. Parveen Gupta as the Managing Director and Mr. Sachin Gupta as a Whole-time Director of the Company for a further period of five (5) consecutive years commencing from July 21, 2027 and ending on July 20, 2032, on the terms and conditions, including remuneration, as set out in the Notice convening the ensuing Annual General Meeting.

5. Based on the recommendation of the NRC, the Board, at its meeting held on September 04, 2026, approved, subject to the approval of the Members, the continuation of the Directorship of Mr. Yogesh Lohiya (DIN: 00424142) as an Non- Executive Independent Director of the Company post attaining the age of 75 years, in accordance with the applicable provisions of the Act and the Listing Regulations.

6. Based on the recommendation of the NRC, the Board, at its meeting held on September 03, 2026, approved, subject to the approval of the Members, appointment of Mr. Rajesh Arora (DIN: 00341999) as an Additional Director, designated as a Non-Executive Independent Director of the Company, subject to receipt of prior approvals from the National Stock Exchange of India Limited (NSE), BSE Limited (BSE), Multi Commodity Exchange of India Limited (MCX), Metropolitan Stock Exchange of India Limited (MSEI), and National Commodity and Derivatives Exchange (NCDEX).

16. Declaration given by Independent Directors

The Company has received necessary declaration from all the Independent Directors under Section 149(7) of the Act and Regulation 25(8) of the Listing Regulations confirming that they meet the criteria of independence as laid down in Section 149(6) of the Act and Regulation 16(1)(b) of the Listing Regulations.

The Independent Directors have also complied with the Code for Independent Directors as per Schedule IV of the Act. Further, the Independent Directors have been exempted from/successfully qualified, the online proficiency self-assessment test conducted by the Indian Institute of Corporate Affairs.

17. Nomination and Remuneration Policy

The Board has adopted a Nomination and Remuneration Policy on appointment of Board members including criteria for determining qualifications, positive attributes, independence of a director and the policy on remuneration of directors, KMP and other employees, recommended by Nomination and Remuneration Committee in terms of the provisions of Section 178 of the Act and Regulation 19 of the Listing Regulations, read with Part D of Schedule II thereto.

The objective of the Policy is to ensure that:

• The level and composition of remuneration is reasonable and sufficient to attract, retain and motivate Directors, Key Managerial Personnel(s) and Senior Management Personnel(s) of the quality required to run the Company successfully;

• Relationship of remuneration to performance is clear and meets appropriate performance benchmarks; and

• Remuneration to Directors, Key Managerial Personnel(s) and Senior Management Personnel(s) involves a balance between fixed and incentive pay reflecting short and long-term performance objectives appropriate to the working of the Company and its goals.

A copy of said policy is placed on the website of the Company. (Click here to view)

18. Meeting of the Board and Committees

The Companys Board is constituted in compliance with the Act and Listing Regulations. The Board functions either as a full Board or through various Committees constituted to oversee specific areas. The Board has, inter alia, constituted requisite mandatory Committees, viz., Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Corporate Social Responsibility Committee and Risk Management Committee. The constitution of these Committees is in compliance with the provisions of the Act and Listing Regulations.

The Board of Directors met five times during financial year 2025-26. The necessary quorum was present for all the meetings. The maximum interval between any two consecutive meetings did not exceed 120 days.

The details of composition, terms of reference and meetings held and attended by the Director and the Committee members of Audit Committee, Nomination and Remuneration Committee, Stakeholders Relationship Committee, Corporate Social Responsibility Committee and Risk Management Committee are provided in the Corporate Governance Report, annexed as Annexure - 1 to this Report.

19. Directors? Responsibility Statement

Pursuant to Section 134 of the Act, your Directors confirm that:

a) i n the preparation of the annual accounts, the applicable accounting standards have been followed along with proper explanation relating to material departures;

b) they have, in the selection of the accounting policies, consulted the Statutory Auditors and these have been applied consistently and reasonable and prudent judgments and estimates have been made so as to give a true and fair view of the state of affairs of the Company as at March 31, 2026 and of the profit of the Company for the year ended on that date;

c) proper and sufficient care has been taken for the maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding the assets of the Company and for preventing and detecting fraud and other irregularities;

d) the Directors have prepared the annual accounts on a going concern basis;

e) they have laid down Internal Financial Control followed by the Company and that such internal financial controls are adequate and were operating effectively; and

f) they have devised proper systems to ensure compliance with the provisions of all applicable laws and the systems were adequate and operating effectively.

20. Statutory Auditor & Auditors? Report

Pursuant to the provisions of Section 139 of the Act and Rules made thereunder, MSKA & Associates, Chartered Accountants (Firm Registration no. 105047W), was appointed by the Members of the Company as the Statutory Auditors of the Company for a term of 5 consecutive years, starting from the conclusion of 30th Annual General Meeting till the conclusion of 35th Annual General Meeting of the Company.

The Auditors have confirmed that they are not disqualified from continuing as the Auditors of the Company.

MSKA & Associates LLP, Chartered Accountants, have submitted their Report on the Financial Statements of the Company for FY 2025-26. There is no qualification, reservation, adverse remark or disclaimer in the said Report.

The Auditors have also confirmed that they have subjected themselves to the peer review process of Institute of Chartered Accountants of India (ICAI) and hold a valid certificate issued by the Peer Review Board of the ICAI.

Further, MSKA & Associates, Chartered Accountants, have intimated the Company that their firm has been converted into a Limited Liability Partnership (LLP) w.e.f. January 13, 2026, in accordance with the provisions of the Limited Liability Partnership Act, 2008 and is known as MSKA & Associates LLP, Chartered Accountants (Firm Registration No.: 105047W/W101187).

During the year under review, the Auditors had not reported any matter under Section 143(12) of the Act. Therefore, no detail is required to be disclosed under Section 134(3)(ca) of the Act.

21. Internal Auditors

The Board of Directors at its meeting held on July 30, 2025, appointed M/s Anshul K Jain & Co., Chartered Accountants (Firm Registration No.: 024042C), as the Internal Auditors of the Company for the financial year 2025-26. Accordingly, M/s Anshul K Jain & Co. have conducted the internal audit of the Company for the said financial year.

Further, the Board of Directors, at its meeting held on May 19, 2026, appointed M/s Jagjit Malik & Associates, Chartered Accountants, as the Internal Auditors of the Company for the financial year 2026-27.

22. Secretarial Auditor & Secretarial Auditors? Report

Pursuant to the provisions of Section 204 of the Act, and based on the recommendation of the Board of Directors and approval of the Members at the 31st Annual General Meeting, M/s Abhishek Gupta & Associates, Company Secretaries (FCS No.: 9857; CP No.: 12262 & Peer Review Certificate No.: 2375/2022) were appointed as Secretarial Auditors of the Company for a term of 5 (five) consecutive years from financial year 2025-2026 to financial year 2029-2030.

The Secretarial Audit Report issued by the Secretarial Auditors for the said financial year 2025-26 does not contain any qualification, observation or adverse remark. The Report is annexed herewith as Annexure - 2A.

The Secretarial Auditors have also confirmed that they are not disqualified from continuing as Secretarial Auditors of the Company under the applicable provisions of law.

Further, in terms of Regulation 24A of the Listing Regulations, Secretarial Audit Report in respect of the Material Subsidiary of the Company, namely Share India AlgoPlus Private Limited, is annexed to this Report as Annexure - 2B.

23. Particulars of Loans, Guarantees or Investments

The full particulars of the loans given, investment made or guarantee given or security provided and the purpose for which the loan or guarantee or security is proposed to be utilized, if any, as per the provisions of Section 186 of the Act are provided in the notes accompanying the Standalone Financial Statements.

24. Particulars of Contract or Arrangement with Related Parties

All related party transactions that were entered into during the financial year 2025-26 were on an arms length basis and were in the ordinary course of business. During the year, the Company did not enter into any contract / arrangement / transaction with related parties which could be considered material in accordance with the related party transactions policy of the Company or which is required to be reported in Form AOC-2 prescribed under Section 134(3)(h) of the Act and Rule 8(2) of the Companies (Accounts) Rules, 2014.

For the purpose of determination of related party, related party transactions and review mechanism relating to such transactions, the Company has formulated the related party transactions policy. The same is published on the website of the Company (Click here to view).

Further, your attention is also drawn to the Related Party disclosures as set out in Note no. 52 of the Standalone Financial Statements.

25. Material Changes and Commitments, if any, affecting the Financial Position of the Company.

There have been no material changes and commitments affecting the financial position of the Company since the close of the financial year ended March 31,2026 and the date of this report.

26. Annual Evaluation of the Performance of the Board, its Committees and Individual Directors.

The annual evaluation process of individual Directors, the Board and Committees was conducted in accordance with the provisions of the Act and the Listing Regulations.

The Nomination and Remuneration Committee of the Board has defined the evaluation criteria and mechanism for assessing the performance of the Board, its Committees, and individual Directors and is also responsible for overseeing the evaluation process and presenting a summary of the results to the Board of Directors.

The Board evaluated its own performance after seeking inputs from all the Directors and the performance of the Committees was evaluated by the Members of the Committee on the basis of criteria such as the composition, effectiveness and whether adequate independence of the Committee is ensured from the Board. The Performance Evaluation of Individual directors was done by all the Directors except the Director being evaluated on the basis of criteria such as actively taking initiatives with respect to various areas, understanding and fulfilment of functions as assigned by Board and law and participation in the meetings.

In a separate meeting of Independent Directors, performance of Non-Independent Directors and the Board as a whole was evaluated. In the said meeting, the Independent Directors also evaluated the performance of Chairman of the Board, taking into account the views of Executive and Non-Executive Directors, and further assessed the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties.

Every Director was required to fill the questionnaire related to the performance of the Board, its Committees and individual Directors except himself by rating the performance on each question. On the basis of the response to the questionnaire, a matrix reflecting the ratings was formulated and collated by the Nomination and Remuneration Committee and provided to Chairman of Board which was then presented/placed before Board by Chairman. The Board was satisfied with the evaluation results.

27. Additional Disclosure as per Schedule V read with Regulation 34 (3) of the Listing Regulations.

a) Related Party Disclosure

The Company is in compliance with IND AS-24 on related party disclosure. For further details, please refer to Note No. 52 forming part of Standalone Financial Statements.

b) Management Discussion and Analysis Report

The Management Discussion and Analysis Report forms an integral part of this Report and is annexed as Annexure - 3.

c) Corporate Governance Report

The Corporate Governance Report forms an integral part of this Report and is annexed as Annexure - 1.

d) Declaration by Chief Executive Officer

A declaration duly signed by Chief Executive Officer stating that the members of Board of Directors and Senior Management Personnel have affirmed compliance with the code of conduct for Board of Directors and Senior Management is annexed to the Corporate Governance Report. Please refer Annexure - 1, i.e., Corporate Governance Report for more details.

e) Compliance Certificate

The Compliance Certificate regarding compliance of conditions of Corporate Governance forms part of the Corporate Governance Report, which is annexed as Annexure - 1 .

f) Disclosures with respect to Demat Suspense Account/ Unclaimed Suspense Account

As on March 31, 2026, there were no securities in the Demat Suspense Account/ Unclaimed Suspense Account.

g) Disclosure of certain types of agreements binding listed entities

During the financial year 2025-26, there were no transactions with respect to the agreements as per clause 5A of part A of para-A of Schedule III, of the Listing Regulations.

28. Conservation of Energy and Technology Absorption

Although the operations of the Company are not energy intensive, the management remains conscious of the importance of energy conservation and technology absorption across all levels of operations. The Company continues to make sustained efforts in this direction on an ongoing basis.

Considering the nature of its business activities, the particulars required under Section 134(3)(m) of the Act read with Rule 8 of the Companies (Accounts) Rules, 2014 relating to conservation of energy and technology absorption are not applicable to the Company and, accordingly, no disclosure in this regard is being made.

29. Foreign Exchange Earnings and Outgo

The Company has incurred an expenditure of 93.91 Lakhs in foreign exchange and has earned 466.26 Lakhs in foreign exchange during the Financial Year 2025-26.

30. Secretarial Standards

Your Company is in compliance with the Secretarial Standards on Meetings of the Board of Directors (SS-1) and Secretarial Standards on General Meetings (SS-2) issued by the Institute of Company Secretaries of India (ICSI).

31. Business Risk Management

Your Company has in place a structured Risk Management framework aimed at strengthening the control environment by identifying, assessing, and mitigating risks that could potentially impact its business operations. The framework seeks to ensure that risks are managed within acceptable levels through appropriate and cost-effective control measures, thereby safeguarding the Companys assets and business continuity.

I n furtherance of this objective, the Board of Directors has adopted a Risk Management Policy to systematically identify, evaluate, and address risks associated with the Companys business activities.

Detailed disclosures relating to risk management practices, including the implementation of the Risk Management Policy, key risks identified, and their mitigation measures, are provided in the Management Discussion and Analysis section, forming part of this Annual Report.

32. Cost Records and Cost Audit Report

I n terms with the provisions of Section 148 of the Act read with the Companies (Cost Records and Audit) Rules 2014, maintenance of cost records and appointment of Cost Auditors is not applicable on your Company.

33. Code of Conduct for Prohibition of Insider Trading

The Company has adopted a Code of Conduct to Regulate, Monitor and Report Trading in Securities by Designated Persons and their Immediate Relatives (“the Code”), in accordance with the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 (“PIT Regulations”). The Code is applicable to such Designated Persons and their Immediate Relatives as identified by the Company in accordance with the Code and the PIT Regulations, based on their role and function in the Company or its subsidiaries, their involvement in the operations of the Company, or their access to unpublished price sensitive information (“UPSI”) in the ordinary course of employment. The code also extends to such other employees and their immediate relatives who, by virtue of their position or responsibilities, are reasonably expected to have access to UPSI relating to the Company.

Persons covered under the Code are prohibited from buying, selling, pledging, revoking pledge, gifting, or otherwise dealing in the securities of the Company while in possession of UPSI and during periods when the trading window is closed.

The Board of Directors have approved and adopted the Code and have also approved the Code of Practices and Procedures for Fair Disclosure of Unpublished Price

Sensitive Information, in line with the requirements of the PIT Regulations.

34. Corporate Social Responsibility

The Company has constituted a Corporate Social Responsibility Committee in compliance with the provisions of Section 135 of the Act read with the Companies (Corporate Social Responsibility Policy) Rules, 2014.

With its focus on Corporate Social Responsibility (“CSR”) activities, your Company has incorporated Share India Smile Foundation (“Smile Foundation”) as its wholly-owned subsidiary. Your Company has been undertaking CSR activities through Smile Foundation

i.e., the philanthropic arm of the Share India Group, on a significant scale, upholding the belief that corporates have a special and continuing responsibility towards social development.

As a part of its initiative under the CSR drive, the Company has undertaken projects through Smile Foundation, in the areas of promoting education and healthcare, including special education and preventive healthcare. These projects are in accordance with Schedule VII of the Act and the Companys CSR policy. The CSR Committee of the Company helps the Company to frame, execute, monitor and review the CSR activities of the Company.

The Annual Report on CSR activities of the Company along with the details of unspent CSR Corpus, if any, during the year under review is attached hereto as Annexure - 4.

35. Vigil Mechanism Policy

The Company has adopted a Vigil Mechanism Policy, to provide a formal mechanism to the Directors and employees to report their concerns about unethical behavior, actual or suspected fraud or violation of the Companys Code of Conduct or ethics policy. The Policy provides for adequate safeguards against victimization of employees who avail of the mechanism and also provides for direct access to the Chairman of the Audit Committee. It is affirmed that no personnel of the Company have been denied access to the Audit Committee. A copy of Companys vigil mechanism policy is available on the Companys Website (Click here to view). )

36. Separate Meeting of Independent Directors

During the year under review, the Independent Directors of the Company held their separate meeting on March 16, 2026. In terms of requirements under Schedule IV of the Act and Regulation 25(3) of the Listing Regulations, the Independent Directors at the meeting, inter alia, reviewed the following:

- Performance of Non-Independent Directors and Board as a whole.

- Performance of the Chairman of the Company, taking into account the views of Executive Directors and Non-Executive Directors.

- Assessed the quality, quantity and timeliness of flow of information between the Company Management and the Board that is necessary for the Board to effectively and reasonably perform their duties.

37. Significant and Material Orders Passed by the Regulators or Courts

There are no significant and material orders passed by the Regulators or Courts or tribunal impacting the going concern status and Companys operations in future.

38. Internal Financial Controls

The Company has in place Internal Financial Controls with reference to financial statements, which are designed and implemented in a manner that ensures their adequacy and operational effectiveness. The internal control framework is commensurate with the size, scale and complexity of the Companys operations.

To further strengthen the control environment, the Board has appointed Internal Auditors who directly report to the Audit Committee of the Company. During the year under review, no material or significant observations have been reported by the Internal Auditors with respect to any inefficiency or inadequacy in the internal control systems of the Company.

39. Particulars of Employees

Disclosures pertaining to remuneration and other details as required under Section 197(12) of the Act read with Rule 5(1) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 form part of this Report and is annexed as Annexure - 5.

I n accordance with the provisions of Section 197(12) of the Act read with Rules 5(2) and 5(3) of the Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, a statement containing names of top ten employees in terms of remuneration drawn and the particulars of other employees as required under the aforesaid Rules, forms part of this Report as Annexure -

6. In line with the provisions of Section 136(1) of the Act, the Report and Accounts, as set out therein, are being sent to all the Members of your Company, excluding the aforesaid statement, which will be open for inspection upon request by the Members. Any Member interested in obtaining the particulars of such employees (Annexure

- 6) may write to the Company Secretary at secretarial? shareindia.com.

40. Policy on Prevention of Sexual Harassment of Women at Workplace

Your Company is committed to providing a safe, secure and inclusive work environment for its women employees, who are an integral part of the organisation. In line with this commitment, the Company has adopted

an Anti-Sexual Harassment Policy in accordance with the Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 (“POSH Act”).

To ensure awareness and sensitisation across the organisation, regular training sessions, workshops and awareness programmes on prevention of sexual harassment are conducted. Further, an Internal Complaints Committee (ICC), comprising the requisite number of members as prescribed under the POSH Act, has been constituted to address and redress complaints related to sexual harassment, if any, received from women employees and other women associates.

The following is a summary of sexual harassment complaints received and closed during the

financial year 2025-26:

• Number of complaints of sexual harassment received in the year: 0

• Number of complaints disposed off during the year: 0

• Number of cases pending for more than ninety days: Not Applicable

• Number of workshops or awareness programmes of the POSH ACT carried out: 1 Sessions for all employees of the Company on Awareness session on POSH at the workplace

• Nature of action taken by the Company to make the workplace a respectful and safe place for all employees: Posters & Conducting of Awareness Sessions

41. Compliance with the Maternity Benefit Act, 1961

The Company is committed to upholding the rights and welfare of its employees and ensures full compliance with all applicable labour laws, including the provisions of the Maternity Benefit Act, 1961.

During the financial year, the Company has fully complied with the provisions of the Maternity Benefit Act, 1961, as amended from time to time. All eligible women employees were granted maternity leave and related benefits in accordance with the Act. The Company also ensures that no discrimination is practiced at any stage of employment on the grounds of maternity.

The Company remains committed to fostering a safe, inclusive, and supportive work environment that promotes the well-being of all employees.

42. Directors and Officers Insurance

In compliance with Regulation 25(10) of the Listing Regulations, the Company has taken Directors and Officers Insurance Policy to provide coverage against the liabilities arising on them.

43. Business Responsibility and Sustainability Report

Pursuant to Regulation 34(2)(f) of the Listing Regulations, the Business Responsibility and Sustainability Report (“BRSR”) describing the initiatives taken by the Board from an Environmental, Social and Governance perspective is forming part of the Annual Report and is annexed herewith as Annexure - 7.

44. Other Disclosures

Your Directors confirm that no disclosure or reporting is required in respect of the following matters, as there were no such transactions during the year under review:

i. any proceedings under the Insolvency and Bankruptcy Code, 2016, pending before the National Company Law Tribunal or any other Court by or against the Company;

ii. any instance of one-time settlement with a Bank or Financial Institution;

iii. any instance wherein the Company failed to implement any corporate action within the statutory time limit;

iv. any revisions made in the financial statements and Directors Report of your Company;

v. receipt of remuneration or commission by the Managing Director or Whole-time Directors from any of the Companys Subsidiaries; and

vi. any scheme involving provision of money for the purchase of the Companys own Shares by employees or by trustees for the benefit of employees.

45. Acknowledgement

Your Directors would like to express their sincere appreciation for the co-operation and assistance received from the Companys Bankers, Stock Exchanges, Regulatory Bodies, Stakeholders and other business associates who have extended their valuable sustained support and encouragement during the year under review.

Your Directors also wish to place on record their deep sense of gratitude and appreciation for the commitment displayed by all executives, officers and staff at all levels of the Company, resulting in the successful performance of the Company during the year under review. We look forward to your continued support in the future.

For and on behalf of the Board of Directors

Share India Securities Limited

Parveen Gupta
Date: September 03, 2026 Chairman & Managing Director
Place: Noida DIN: 00013926

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited. All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.